Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

The industry’s intellectual property manipulations are stealing from your pockets—and limiting the benefits of the Biden ...

Aetna is taking legal action against Pfizer, Novartis, Teva Pharmaceuticals and others, saying the list of drugmakers ...

We’ve seen several high-profile transactions in life sciences, resulting in big exits for investors in the private and public ...

Commercialisation partners, which go beyond traditional service providers, can provide emerging companies with the same platform as large pharmaceutical manufacturers while adding the advantages ...